Stock 2Q5 RENOVARO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Renovaro Inc. Deutsche Boerse AG

Equities

2Q5

US29350E1047

Real-time Estimate Tradegate
Other stock markets
 01:35:28 2024-06-13 pm EDT 		5-day change 1st Jan Change
1.362 EUR +0.74% Intraday chart for Renovaro Inc. +2.05% -54.83%
May. 24 Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy MT
May. 24 Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
Renovaro Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Renovaro Inc. Announces Board Changes
Sector Update: Health Care Stocks Gain Late Afternoon
Sector Update: Health Care
Renovaro Shares Jump After Response to Short Seller Hindenburg's Report
Sector Update: Health Care Stocks Decline Late Afternoon
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics
Renovaro Shares Tumble Following Report From Short-Seller Hindenburg
Renovaro Biosciences Inc. completed the acquisition of GEDi Cube Intl Ltd. for $59.2 million.
Top Premarket Gainers
Renovaro Biosciences' Shareholders Approve Share Issuance for Merger Deal With GEDi Cube
Renovaro Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023
Renovaro Biosciences Inc. Appoints Avram Miller as Board of Directors
Renovaro Biosciences Inc. Appoints Leni Boeren and Ruud Hendriks as Independent Directors
Renovaro Biosciences Inc. Reports Earnings Results for the Full Year Ended June 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RENB Stock
  4. 2Q5 Stock
  5. News Renovaro Inc.
  6. Other languages